BioNTech SE BNTX
NASDAQ BNTX
$87.21 -0.30 (-0.34%)
At close: Nov 10, 2026 · 4:00 PM EST

BioNTech SE (BNTX) Research & Development (2018 - 2026)

Updated

BioNTech SE's Research & Development came in at $860.63 million for Q3 2026, up 30.3% from $660.28 million a year earlier and up 34.4% from the prior quarter.

Analysis

BioNTech SE (BNTX) Research & Development (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, BioNTech SE reported Research & Development of $2.74 billion, up 12.2% year-over-year; for FY2025, it was $2.38 billion, down 2.5% from FY2024.

  • Research & Development carries a five-year compound annual growth rate of 26.4% (FY2020 to FY2025).
  • Going back by year, Research & Development was $2.44 billion in FY2024 (+26.5%), $1.93 billion in FY2023 (+19.1%), $1.62 billion in FY2022 (+44.2%) and $1.12 billion in FY2021 (+52.5%).
  • The Q3 2026 figure represents the highest quarterly Research & Development in data going back to Q3 2018.
  • Year-over-year, Research & Development has increased for three consecutive quarters, with growth averaging 7.0% over the last eight quarters.
  • The fastest year-over-year change in Research & Development over five years came in Q2 2022 (growth of 76.1%), and the weakest in Q4 2025 (a decline of 10.0%).
  • Business Quant data shows BNTX's Research & Development at $640.46 million (Q2 2026), $652.11 million (Q1 2026) and $588.31 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 4.65 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 2.57 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 4.05 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 1.61 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 3.02 Bn
10 BioNTech SE 21.19 Bn -49.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 860.63 Mn
Jun 30, 2026 640.46 Mn
Mar 31, 2026 652.11 Mn
Dec 31, 2025 588.31 Mn
Sep 30, 2025 660.28 Mn
Jun 30, 2025 576.28 Mn
Mar 31, 2025 552.87 Mn
Dec 31, 2024 653.77 Mn
Sep 30, 2024 604.35 Mn
Jun 30, 2024 629.55 Mn
Mar 31, 2024 551.33 Mn
Dec 31, 2023 621.68 Mn
Sep 30, 2023 542.01 Mn
Jun 30, 2023 406.60 Mn
Mar 31, 2023 358.50 Mn
Dec 31, 2022 520.12 Mn
Sep 30, 2022 344.63 Mn
Jun 30, 2022 426.40 Mn
Mar 31, 2022 320.76 Mn
Dec 31, 2021 310.59 Mn
API Access

BioNTech SE Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=BNTX&period=max&api_key=YOUR_API_KEY